Revision history of "The Cycle One Dosage Escalation Research associated with Neoadjuvant SBRT As well as Suggested Nodal Light with Contingency Capecitabine pertaining to Resectable Pancreatic Cancer malignancy"

From EECH Central
Jump to: navigation, search

Diff selection: Mark the radio boxes of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

  • (cur | prev) 12:56, 12 April 2024‎ Barswing39 (Talk | contribs)‎ . . (3,116 bytes) (+3,116)‎ . . (Created page with "27 ± 0.Thirty four as well as 2.45 ± 0.Forty four following 12 months without any statistical value big difference (p= 0.195). Your STT assessment revealed a in...")
Retrieved from "http://eechcentral.simhq.com/index.php?title=The_Cycle_One_Dosage_Escalation_Research_associated_with_Neoadjuvant_SBRT_As_well_as_Suggested_Nodal_Light_with_Contingency_Capecitabine_pertaining_to_Resectable_Pancreatic_Cancer_malignancy"